The pharmaceutical-sales field, often called "recession-proof," is popular because it offers excellent salary potential, great benefits, flexibility, opportunity for growth, and frequently the use of ...

There are several compelling reasons to invest in pharmaceutical companies, especially when the economy isn't doing well.

Sales of Takhzyro amounted to 44.1 billion Japanese yen in the 3rd quarter of 2022, an increase of 42.7% from the previous year. Takeda Pharmaceutical's revenue was $8,354 million in Q3 2022, showing ...

In order to end this pandemic, everyone must play their part, and that includes the private sector. Their leadership, innovation, skills, knowledge, and financial muscle are desperately needed. This ...

The United States has a $115.5 billion trade deficit in pharmaceutical products, which the Trump administration has suggested it may try to equalize through tariffs.

On this week’s JOURNAL, Bill Moyers spoke with Melody Petersen, an independent journalist who formerly covered the drug industry for the NEW YORK TIMES and is author of OUR DAILY MEDS: HOW THE ...

When you take aspirin for a headache, how does the aspirin know to travel to your head and alleviate the pain? The short answer is, it doesn’t: Molecules can’t transport themselves through the body, ...

Trump threatened 100 percent tariffs on certain brand-name drugs last week. The administration is using the threat to secure ...

This article first appeared in the newsletter Your Local Epidemiologist. Pharmaceutical ads in the United States are annoying. Absurd. And almost uniquely American. In fact, only one other high-income ...

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both. The popular research ...